Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
29,64 USD | -1,72% | -2,60% | -10,26% |
28/03 | EVOLENT HEALTH, INC. : Canaccord Genuity ontvangt een koopadvies | ZM |
15/03 | EVOLENT HEALTH, INC. : JPMorgan Chase geeft koopadvies | ZM |
Omzet 2024 * | 2,47 mld. 2,31 mld. | Omzet 2025 * | 2,86 mld. 2,68 mld. | Marktkapitalisatie | 3,38 mld. 3,16 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 19 mln. 17,79 mln. | Nettowinst (verlies) 2025 * | 69 mln. 64,62 mln. | EV/omzet 2024 * | 1,53 x |
Nettoschuld 2024 * | 391 mln. 366 mln. | Nettoschuld 2025 * | 272 mln. 254 mln. | EV/omzet 2025 * | 1,28 x |
K/w-verhouding 2024 * |
1.160
x | K/w-verhouding 2025 * |
61,6
x | Werknemers | 4.700 |
Dividendrendement 2024 * |
0,91% | Dividendrendement 2025 * |
0,85% | Vrij verhandelbaar | 94,57% |
Recentste transcriptie over Evolent Health, Inc.
1 dag | -1,72% | ||
1 week | -2,60% | ||
Lopende maand | -9,61% | ||
1 maand | -9,22% | ||
3 maanden | -2,98% | ||
6 maanden | +4,81% | ||
Lopend jaar | -10,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Seth Blackley
FOU | Founder | 45 | 01-08-11 |
Dan McCarthy
PSD | President | - | 15-09-22 |
Jessica Somers
DFI | Director of Finance/CFO | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peter Grua
BRD | Director/Board Member | 70 | 01-02-20 |
Richard Jelinek
BRD | Director/Board Member | 59 | 08-06-23 |
Cheryl Scott
CHM | Chairman | 74 | 01-11-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.80% | 12 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 29,64 | -1,72% | 710 339 |
16-04-24 | 30,16 | -0,46% | 881 789 |
15-04-24 | 30,3 | +0,56% | 768 190 |
12-04-24 | 30,13 | -1,31% | 405 987 |
11-04-24 | 30,53 | +0,33% | 507 337 |
uitgestelde koers Nyse, 17 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,26% | 3,38 mld. | |
+3,47% | 32,15 mld. | |
+5,63% | 6,72 mld. | |
+16,39% | 3,68 mld. | |
-30,19% | 1,21 mld. | |
-38,71% | 1,04 mld. | |
-0,11% | 893 mln. | |
-28,03% | 813 mln. | |
-41,53% | 817 mln. | |
-19,29% | 684 mln. |